Alba Rivera

1.8k total citations
40 papers, 723 citations indexed

About

Alba Rivera is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Alba Rivera has authored 40 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Medicine, 12 papers in Pharmacology and 10 papers in Epidemiology. Recurrent topics in Alba Rivera's work include Antibiotic Resistance in Bacteria (23 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Pneumonia and Respiratory Infections (7 papers). Alba Rivera is often cited by papers focused on Antibiotic Resistance in Bacteria (23 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Pneumonia and Respiratory Infections (7 papers). Alba Rivera collaborates with scholars based in Spain, Australia and United States. Alba Rivera's co-authors include Beatriz Mirelis, Pere Coll, Ferrán Navarro, Elisenda Miró, Núria Prim, Mercè Gurguí, Montserrat Español, María José Añón Roig, Antonio Oliver and Montserrat Sabaté and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Alba Rivera

34 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alba Rivera Spain 16 518 199 165 157 156 40 723
Maud Nilsson Sweden 16 650 1.3× 281 1.4× 237 1.4× 154 1.0× 166 1.1× 27 846
Maria Tärnberg Sweden 16 388 0.7× 179 0.9× 114 0.7× 144 0.9× 91 0.6× 21 558
S. Vourli Greece 13 442 0.9× 185 0.9× 92 0.6× 127 0.8× 146 0.9× 20 629
Kyriaki Tryfinopoulou Greece 12 522 1.0× 199 1.0× 150 0.9× 142 0.9× 143 0.9× 30 689
Enno Stürenburg Germany 13 498 1.0× 246 1.2× 131 0.8× 198 1.3× 87 0.6× 18 731
Jean‐Luc Donay France 11 533 1.0× 223 1.1× 140 0.8× 214 1.4× 91 0.6× 18 737
Gioconda Brigante Italy 13 399 0.8× 165 0.8× 104 0.6× 233 1.5× 110 0.7× 22 605
Evangelia Dimitroulia Greece 13 556 1.1× 203 1.0× 123 0.7× 244 1.6× 235 1.5× 25 853
Olfa Bouallègue Tunisia 17 609 1.2× 290 1.5× 221 1.3× 123 0.8× 118 0.8× 43 736
Patricia J. Baudry Canada 11 487 0.9× 165 0.8× 113 0.7× 176 1.1× 162 1.0× 17 683

Countries citing papers authored by Alba Rivera

Since Specialization
Citations

This map shows the geographic impact of Alba Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Rivera more than expected).

Fields of papers citing papers by Alba Rivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Rivera. The network helps show where Alba Rivera may publish in the future.

Co-authorship network of co-authors of Alba Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Rivera. A scholar is included among the top collaborators of Alba Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Rivera. Alba Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mur, Isabel, Laura Morata, Alba Rivera, et al.. (2025). Exploring the Microbiome of Diabetic Foot Ulcers: A Focus on Cases with a Clinical Worse Outcome. Antibiotics. 14(7). 724–724.
3.
Ramos, Jesús Ruiz, et al.. (2023). The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department. Antibiotics. 12(10). 1522–1522. 4 indexed citations
4.
Pomar, Virginia, et al.. (2023). Acute Bacterial Meningitis in Healthy Adult Patients: A Prospective Cohort Study. Journal of Clinical Medicine. 12(11). 3624–3624.
5.
Rivera, Alba, Sònia Luque, Isabel Mur, et al.. (2020). Intraoperative Bacterial Contamination and Activity of Different Antimicrobial Prophylaxis Regimens in Primary Knee and Hip Replacement. Antibiotics. 10(1). 18–18. 9 indexed citations
6.
Mur, Isabel, Marcos Jordán, Alba Rivera, et al.. (2020). Do Prosthetic Joint Infections Worsen the Functional Ambulatory Outcome of Patients with Joint Replacements? A Retrospective Matched Cohort Study. Antibiotics. 9(12). 872–872. 14 indexed citations
7.
Sánchez, A, Natividad Benito, Alba Rivera, et al.. (2020). Pathogenesis of Staphylococcus epidermidis in prosthetic joint infections: can identification of virulence genes differentiate between infecting and commensal strains?. Journal of Hospital Infection. 105(3). 561–568. 14 indexed citations
8.
Miró, Elisenda, Carmina Martí, Carles Alonso-Tarrés, et al.. (2018). Molecular characterization of OXA-48 carbapenemase-producing Klebsiella pneumoniae strains after a carbapenem resistance increase in Catalonia. Enfermedades Infecciosas y Microbiología Clínica. 37(2). 82–88. 18 indexed citations
9.
Prim, Núria, et al.. (2017). Prevalence of colistin resistance in clinical isolates of Enterobacteriaceae: A four-year cross-sectional study. Journal of Infection. 75(6). 493–498. 49 indexed citations
10.
López-Hernández, Inmaculada, Marta Fernández-Martínez, Laura Zamorano, et al.. (2016). Activity of ceftazidime–avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance. Enfermedades Infecciosas y Microbiología Clínica. 35(8). 499–504. 10 indexed citations
11.
Pascual, V., María Simó, Mariona Xercavins, et al.. (2016). Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features. European Journal of Clinical Microbiology & Infectious Diseases. 35(12). 1997–2003. 12 indexed citations
12.
Rivera, Alba, Nieves Larrosa, Beatriz Mirelis, & Ferrán Navarro. (2014). Importancia de los controles de calidad para la detección de la resistencia a antibióticos β-lactámicos en enterobacterias. Enfermedades Infecciosas y Microbiología Clínica. 32. 30–36. 2 indexed citations
13.
Miró, Elisenda, et al.. (2009). Prevalence of acquired AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clinical Microbiology and Infection. 16(5). 472–476. 40 indexed citations
14.
Mirelis, Beatriz, et al.. (2006). A simple phenotypic method for differentiation between acquired and chromosomal AmpC β-lactamases in Escherichia coli. Enfermedades Infecciosas y Microbiología Clínica. 24(6). 370–372. 37 indexed citations
15.
Rivera, Alba, F Sánchez, Ferrán Navarro, et al.. (2005). Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain. Clinical Microbiology and Infection. 11(9). 759–761. 22 indexed citations
16.
Miró, Elisenda, Beatriz Mirelis, Ferrán Navarro, et al.. (2005). Surveillance of extended-spectrum β-lactamases from clinical samples and faecal carriers in Barcelona, Spain. Journal of Antimicrobial Chemotherapy. 56(6). 1152–1155. 66 indexed citations
17.
Rivera, Alba. (1997). Aproximación al marco teórico y metodológico en la investigación de geografía del género. Cuadernos Geográficos. 7–28. 2 indexed citations
18.
Rivera, Alba. (1996). Dona i reestructuració a les àrees rurals: el cas de l'agroturisme a les comarques del Solsonès, el Bages i el Berguedà. Hispana. 37–100. 2 indexed citations
20.
Rivera, Alba. (1995). SPAIN, Daphne. Gendered Spaces. Documents d Anàlisi Geogràfica. 342–345.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026